JJ

Jyoti Jain

Active Director Director DIN 01287739
DIN 01287739 First appointment Dec 2002 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2002
Shareholding value •••• Premium profile

About Jyoti Jain

Data last updated:

Jyoti Jain is a Director at Jvj Pharmaceuticals Private Limited (since 2002). The company operates in Pharma. Jvj Pharmaceuticals Private Limited reported revenue of ₹3.07 Cr (FY 2025).

DIN 01287739
Primary Designation Director
Industry Pharma
First Appointment 31 Dec 2002
Oldest Company Age 23 yrs
Largest company Jvj Pharmaceuticals Private Limited · ₹3.07 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jvj Pharmaceuticals Private Limited U24232MP2002PTC015479
Director31 Dec 20022002₹3.07 Cr (FY 2025)Active

Board colleagues of Jyoti Jain

NameDINCompanyDesignation
Vikas Jain00096538Jvj Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Jvj Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jyoti Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyoti Jain

Jyoti Jain currently holds 1 directorship: Jvj Pharmaceuticals Private Limited (Director, since 31 Dec 2002, revenue ₹3.07 Cr (FY 2025)).

Jyoti Jain was first appointed on 31 Dec 2002 as Director at Jvj Pharmaceuticals Private Limited.

The current boards of Jyoti Jain's companies include Vikas Jain (Jvj Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available